ORGANIZATION/SPONSOR: Harvard Office of Technology Development and the FAS Office of Postdoctoral Affairs
SPEAKER(S): Prof. Douglas Melton (Harvard University); Semma Therapeutics CEO Robert Millman; and Semma VP and former Harvard postdoc Felicia Pagliuca.
TICKET WEB LINK: melton-semma.eventbrite.com
CONTACT INFO: email@example.com
Harvard-launched startup Semma Therapeutics has licensed innovations from Prof. Doug Melton’s lab that enable the generation of billions of functional, insulin-producing beta cells in the laboratory. Join us to hear a discussion with the cofounders.
The Commercializing Innovation speaker series is primarily intended for Harvard University faculty, postdoctoral researchers, and graduate students who are interested in learning about technology commercialization, careers outside of academia, and scientific entrepreneurship. However, the event is open to all.